Skip to main content
. 2023 May 1;15:327–335. doi: 10.2147/BCTT.S407896

Figure 2.

Figure 2

The pCR rate of patients with HER2-low, HER2-0, HR+/HER2-low, HR+/HER2-0, HR-/HER2-low, and HR-/HER2-0. No significant difference was observed in the whole, HR+ and HR- populations (P = 0.468, P = 0.937 and P = 0.795, respectively).